Accelerating Medical Affairs, 2025
October 24, 2025 · Online
Harnessing Generative AI (Gen AI) for evidence, engagement, and impact
Sahar Alothman
Global Scientific Director
AstraZeneca
Dr. Sahar J. Alothman, Ph.D. is an accomplished medical and scientific director specializing in oncology and scientific education. At AstraZeneca, she leads global initiatives to advance cancer therapeutics and optimize medical training. Dr. Alothman has pioneered the development of innovative training approaches, integrating AI-driven learning and digital health solutions to elevate scientific engagement and retention across diverse medical teams. With an interdisciplinary background in tumor biology and a proven record of spearheading clinical trials, educational programs, and evidence generation, she is dedicated to enhancing patient care through technology and collaboration. Dr. Alothman’s work exemplifies the transformative impact of AI in medical learning and professional development, positioning her as a thought leader in leveraging artificial intelligence for healthcare innovation.
Sessions
Jared Wels, PhD
2:00 PM – 2:30 PM
Smarter Training for Smarter Conversations: Gen AI for MSL Training and Readiness
- Elevate MSL Impact: Learn how MSLs can transition from data carriers to strategic partners through innovative engagement strategies and adaptive, AI-driven training tools.
- Enhance Learning Efficiency: Discover how Gen AI and patient case-based simulations can provide on-demand, realistic HCP interaction practice aligned with adult learning principles.
- Ensure Training Excellence: Explore best practices for maintaining accuracy, compliance, and human oversight in AI-powered learning environments for MSL development
Jared Wels, PhD, Practice Leader, AI & Innovation, Real Chemistry Medical Communications
Sahar Alothman, Global Scientific Director, AstraZeneca